The Southwest Oncology Group: Progress in Cancer Research
Beginning in the mid 1950s and continuing through today, the Southwest Oncology Group (SWOG) has been a leader in cancer clinical research in adults. SWOG has contributed to the field of cancer research through both the logistical development of new systems, technologies, statistical methodologies, and training, and through specific tangible contributions to science, addressing the standard of care for almost every adult malignancy. This review summarizes the highlights of SWOG contributions over the years, including contributions in medical oncology, staging, radiation oncology, surgery, and other cancer-related disciplines.
To access this article, please choose from the options below
Supported in part by the grants awarded by the following Institutes of the Department of Health and Human Services: National Cancer Institute—CA32102, CA37429 and the National Center for Complementary and Alternative Medicine, CA108964; National Institute of Aging—AG19241; National Eye Institute—EY014418; and National Heart, Lung, and Blood Institute—HL071022.
PII: S0093-7754(08)00164-4
doi:10.1053/j.seminoncol.2008.07.001
© 2008 Elsevier Inc. All rights reserved.
